Bell Investment Advisors, Inc Harmony Biosciences Holdings, Inc. Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 23 shares of HRMY stock, worth $896. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$896% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
45.6MCall Options Held
111KPut Options Held
46.9K-
Valor Management LLC Chicago, IL6.62MShares$258 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$227 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$185 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$61.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...